Webinars
Unraveling Complexities in Nasal Vaccine Development, Manufacturing and Device Selection
Listen to this webinar to hear experts share insights into developing intranasal vaccine analytical tools, how to improve the speed and quality of critical batch release and characterization assays and the importance of device selection in determining product performance.
View Now
Poster
PBPK Modeling as a Strategic Tool to Predict Intranasal Drug Absorption
The aim of this study was to verify if the GastroPlus® PBPK software can be used to predict intranasal absorption by comparing predictions with human intranasal pharmacokinetic data from the literature.
View Now
Webinars
Key Considerations for Selection and Encapsulation of Capsules for Dry Powder Inhalation
Watch this webinar to gain insights into current market trends in dry powders for inhalation, the key capsule characteristics that determine performance and the fundamental physical characteristics of spray-dried and lactose-based powders that contribute to the efficiency of the encapsulation process.
View Now
Article
Intranasal Drug Product Development - From Formulation to Scaleup Manufacturing
Summary: In this Q&A article, experts discuss intranasal drug product development, in particular best practices and key considerations, from formulation design to manufacture and scale-up.
View Now
Article
Emerging Trends and Opportunities in Orally Inhaled Drug Products
Summary: In this Q&A article, Catalent experts Carolyn Berg and Carla Vozone discuss innovations in orally inhaled drug products, in particular dry powders for inhalation.
View Now
Webinars
Intranasal Drug Delivery-Identifying Challenges and New Product Opportunities
Intranasal delivery is emerging as an alternative route of systemic drug delivery for a variety of indications such as migraine, seizures, breakthrough pain and opioid overdose and more.
View Now
Article
Article: Industry Trend: Examining the Emergence of Unit- & Bi-Dose Nasal Sprays
Summary: Molecules that are limited by a slow onset of action, a suboptimal side-effect profile, or a complicated administration process, may be good candidates for adaptation to a unit- or...
View Now
eBook
Orally Inhaled & Nasal Drug Delivery – An Evolving Pipeline Creating New Opportunities
Catalent’s Carla Vozone discusses the significant inhalation trends including those in larger molecules and novel indications.
View Now
Webinars
Reducing Inhalation Burden Through High-Dose, Carrier-Free Spray Dry Powders
Explore how spray dried particles provide an attractive, carrier-free option for highly dispersed delivery of API to deep lung regions.
View Now
Article
Industry Trend: Examining the Emergence of Unit- & Bi-Dose Nasal Sprays
Summary: Molecules that are limited by a slow onset of action, a suboptimal side-effect profile, or a complicated administration process, may be good candidates for adaptation to a unit- or...
View Now